Hall Laurie J Trustee Lexicon Pharmaceuticals, Inc. Transaction History

Hall Laurie J Trustee

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	SELL	$1.8 - $2.56 $756 - $1,075	-420 Reduced 36.84%	720 $1,000
Q3 2022 Oct 11, 2022	SELL	$1.94 - $3.43 $989 - $1,749	-510 Reduced 30.91%	1,140 $3,000
Q3 2021 Oct 04, 2021	SELL	$3.38 - $5.35 $4,157 - $6,580	-1,230 Reduced 42.71%	1,650 $8,000
Q1 2021 Apr 15, 2021	BUY	$3.45 - $9.09 $5,347 - $14,089	1,550 Added 116.54%	2,880 $17,000
Q4 2020 Jan 25, 2021	BUY	$1.05 - $3.67 $1,029 - $3,596	980 Added 280.0%	1,330 $5,000
Q3 2020 Oct 09, 2020	BUY	$1.44 - $2.1 $172 - $252	120 Added 52.17%	350 $1,000
Q4 2017 Jan 30, 2018	SELL	$8.77 - $12.28 $964 - $1,350	-110 Reduced 32.35%	230 $2,000
Q2 2017 Aug 22, 2017	BUY	N/A	340	340 $0

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $134M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.